Professor David Sharp is a neurologist and Centre Director of UK DRI Care Research & Technology, focusing on using technology to enhance the lives of people living with dementia. He is also Scientific Director of the Imperial College Clinical Imaging Facility and Associate Director of the Imperial Centre for Injury Studies. His research programme aims to improve clinical outcomes after dementia and traumatic brain injury (TBI), focusing on common cognitive impairments in domains such as memory and attention. He uses cognitive neuroscience and advanced neuroimaging to investigate the effect of brain injury on brain network function and the effects of inflammation and neurodegeneration. His has explored how new treatments of cognitive impairment can be personalised and his current work focuses on harnessing neurotechnology development to improve the lives of those living with dementia and the effects of brain injury.
et al., 2021, White matter abnormalities in active elite adult rugby players, Brain Communications, ISSN:2632-1297
et al., 2021, Multiscale modelling of cerebrovascular injury reveals the role of vascular anatomy and parenchymal shear stresses, Scientific Reports, Vol:11, ISSN:2045-2322
et al., 2021, Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps, International Journal of Geriatric Psychiatry, ISSN:0885-6230
et al., 2021, Psychotropic and pain medication use in individuals with traumatic brain injury-a Swedish total population cohort study of 240 000 persons, Journal of Neurology Neurosurgery and Psychiatry, Vol:92, ISSN:0022-3050, Pages:519-527
et al., 2021, Distributional gaussian process layers for outlier detection in imagesegmentation, Information Processing in Medical Imaging (IPMI) 2021, arXiv